Physician profile
Cyril Abrams
NPI 1821098344
$5,659.20
in general payments reported to CMS, 2019-2025
40 companies · $395 in 2025
The $395 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,250 · 2020: $392 · 2021: $816 · 2022: $979 · 2023: $851 · 2024: $976 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,222.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $871.00 | 2022-2025 | |
| Amgen INC. | $607.16 | 2019-2025 | Repatha, Otezla |
| Astrazeneca Pharmaceuticals Lp | $490.34 | 2019-2024 | Farxiga |
| Janssen Pharmaceuticals, INC | $447.39 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $335.23 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $273.86 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $260.08 | 2022-2025 | Camzyos, Eliquis |
| Lilly USA, LLC | $231.59 | 2019-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $181.53 | 2021-2025 | |
| Preventric Diagnostics, INC. | $173.52 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $150.31 | 2019-2021 | |
| Abbott Laboratories | $148.10 | 2019-2024 | Mitraclip, Amplatzer Amulet, Freestyle Libre 3 |
| Genzyme Corporation | $140.19 | 2019-2024 | |
| Daiichi Sankyo INC. | $105.80 | 2022-2024 | Injectafer |
| Philips North America LLC | $102.01 | 2022-2024 | (5050) Extended Holter, (Ck7) Extended Holter |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cyril Abrams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.